These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2087485)
41. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW; Binder HJ Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [TBL] [Abstract][Full Text] [Related]
42. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. Yamada S; Isogai M; Okudaira H; Hayashi E J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862 [TBL] [Abstract][Full Text] [Related]
43. Divergent regulation of muscarinic binding sites and acetylcholinesterase in discrete regions of the developing human fetal brain. Egozi Y; Sokolovsky M; Schejter E; Blatt I; Zakut H; Matzkel A; Soreq H Cell Mol Neurobiol; 1986 Mar; 6(1):55-70. PubMed ID: 3719620 [TBL] [Abstract][Full Text] [Related]
44. Fasciculin inhibition of acetylcholinesterase is prevented by chemical modification of the enzyme at a peripheral site. Durán R; Cerveñansky C; Dajas F; Tipton KF Biochim Biophys Acta; 1994 Dec; 1201(3):381-8. PubMed ID: 7803468 [TBL] [Abstract][Full Text] [Related]
45. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998 [TBL] [Abstract][Full Text] [Related]
46. A comparison of the distribution of acetylcholinesterase and muscarinic cholinergic receptors in the feline neostriatum. Brand S Neurosci Lett; 1980 Apr; 17(1-2):113-7. PubMed ID: 7052452 [TBL] [Abstract][Full Text] [Related]
47. Comparative in vivo effects of parathion on striatal acetylcholine accumulation in adult and aged rats. Karanth S; Liu J; Ray A; Pope C Toxicology; 2007 Oct; 239(3):167-79. PubMed ID: 17707571 [TBL] [Abstract][Full Text] [Related]
48. A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure. Costa LG; Fox DA Brain Res; 1983 Oct; 276(2):259-66. PubMed ID: 6627009 [TBL] [Abstract][Full Text] [Related]
49. Changes in acetylcholinesterase and cholinesterase activities in rat pancreas during postnatal development. Lack of relation with muscarinic receptor maturation. Dumont Y; Larose L; Poirier GG; Morisset J Pharmacology; 1984; 29(1):40-6. PubMed ID: 6463099 [TBL] [Abstract][Full Text] [Related]
50. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. Flynn DD; Mash DC J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841 [TBL] [Abstract][Full Text] [Related]
51. Memory improving actions of gabapentin in mice: possible involvement of central muscarinic cholinergic mechanism. Boccia MM; Acosta GB; Baratti CM Neurosci Lett; 2001 Oct; 311(3):153-6. PubMed ID: 11578817 [TBL] [Abstract][Full Text] [Related]
52. Effects of galanin subchronic treatment on memory and muscarinic receptors. Barreda-Gómez G; Lombardero L; Giralt MT; Manuel I; Rodríguez-Puertas R Neuroscience; 2015 May; 293():23-34. PubMed ID: 25732139 [TBL] [Abstract][Full Text] [Related]
53. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment? Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634 [TBL] [Abstract][Full Text] [Related]
54. Effect of post-training injections of flumazenil into the amygdala, hippocampus and septum on retention of habituation and of inhibitory avoidance in rats. Da Cunha C; Wolfman C; Huang CH; Walz R; Koya R; Bianchin M; Medina JH; Izquierdo I Braz J Med Biol Res; 1991; 24(3):301-6. PubMed ID: 1668398 [TBL] [Abstract][Full Text] [Related]
55. Amygdala modulation of memory consolidation: interaction with other brain systems. McGaugh JL; McIntyre CK; Power AE Neurobiol Learn Mem; 2002 Nov; 78(3):539-52. PubMed ID: 12559833 [TBL] [Abstract][Full Text] [Related]
56. Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. Matsuno K; Senda T; Matsunaga K; Mita S; Kaneto H Psychopharmacology (Berl); 1993; 112(1):134-41. PubMed ID: 7871003 [TBL] [Abstract][Full Text] [Related]
57. Effects of local inhibition of locus coeruleus acetylcholinesterase by fasciculin in rats. Abó V; Viera L; Silveira R; Dajas F Neurosci Lett; 1989 Apr; 98(3):253-7. PubMed ID: 2471117 [TBL] [Abstract][Full Text] [Related]
58. [Influences of intraventricular injection of 6-hydroxydopamine on passive-avoidance response, acetylcholine, and muscarinic receptors in mouse brain]. Pan SY Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):344-7. PubMed ID: 1807084 [TBL] [Abstract][Full Text] [Related]
59. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors. Baker SP; Posner P Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882 [TBL] [Abstract][Full Text] [Related]
60. Correlation of muscarinic receptor density and acetylcholinesterase activity in repeated DFP-treated rats after the termination of DFP administration. Lim DK; Hoskins B; Ho IK Eur J Pharmacol; 1986 Apr; 123(2):223-8. PubMed ID: 3709665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]